Envarsus XR 4 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FUCF8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,849
Award facts
- Contract value 100% obligated
- $12,849.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,849.42 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg, a tacrolimus-based immunosuppressant medication used primarily in transplant patients. This non-competitive, firm fixed-price delivery order, issued on September 22, 2025, with an ultimate completion date of October 14, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is a child contract executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and Defense Health Agency operations worldwide. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to fulfill federal medical procurement requirements through consistent competitive awards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FUCF8?
SPE2DB25FUCF8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FUCF8 worth?
The government has obligated $12,849 on SPE2DB25FUCF8.
Is contract SPE2DB25FUCF8 an order under another contract?
Yes. SPE2DB25FUCF8 is a delivery order under SPE2DB22D1041, an indefinite delivery contract.
Was contract SPE2DB25FUCF8 competed?
The extent of competition for SPE2DB25FUCF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award